Inventiva (IVA) Cash from Financing Activities (2019 - 2022)
Inventiva (IVA) recorded quarterly Cash from Financing Activities of $14.2 million in Q4 2022, down 2.22% quarter-over-quarter from $14.6 million in Q3 2022, and up 40038.88% on a YoY basis from N/an in Q4 2021.
Inventiva (IVA) Cash from Financing Activities (2019 - 2022) Analysis & Trends
Inventiva's Cash from Financing Activities history runs 4 years deep, the most recent figure standing at $14.2 million for Q4 2022.
- In Q4 2022, Cash from Financing Activities rose 40038.88% year-over-year to $14.2 million; the TTM figure through Dec 2022 stood at $28.9 million (down 1.79% YoY), while the FY2025 annual figure was $280.9 million, up 80.53% from the prior year.
- Cash from Financing Activities was $14.2 million for Q4 2022 at Inventiva, down from $14.6 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $29.3 million in Q4 2020 to a low of -$132826.5 in Q4 2019.
- Historically, Cash from Financing Activities has averaged $9.5 million across 4 years, with a median of $11.0 million in 2020.
- The sharpest annual moves came in 2021 and 2022: Cash from Financing Activities plunged 100.12% in 2021, then soared 40038.88% in 2022.
- A 4-year view of Cash from Financing Activities shows it stood at -$132826.5 in 2019, then surged by 22187.97% to $29.3 million in 2020, then sank by 99.88% to $35463.1 in 2021, then jumped by 40038.88% to $14.2 million in 2022.
- The last three Cash from Financing Activities figures came in at $14.2 million (Q4 2022), $14.6 million (Q3 2022), and $35463.1 (Q4 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 7.00 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -600,000.00 |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 53,000.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | -538.80 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 85,464.43 |
| 10 | Inventiva | 8.64 Mn | -260.09 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 14.23 Mn |
| Dec 31, 2022 | 14.23 Mn |
| Sep 22, 2022 | 14.56 Mn |
| Sep 22, 2022 | 14.56 Mn |
| Dec 31, 2021 | 35,463.10 |
| Dec 31, 2021 | 35,463.10 |
| Jun 30, 2021 | 56,600.76 |
| Jun 30, 2021 | 56,600.76 |
| Mar 31, 2021 | -19,299.78 |
| Mar 31, 2021 | -19,299.78 |
| Dec 31, 2020 | 29.34 Mn |
| Dec 31, 2020 | 29.34 Mn |
| Jun 30, 2020 | 10.99 Mn |
| Jun 30, 2020 | 10.99 Mn |
| Mar 31, 2020 | 16.15 Mn |
| Mar 31, 2020 | 16.15 Mn |
| Dec 31, 2019 | -132,826.52 |
| Dec 31, 2019 | -132,826.52 |